EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence of Tick-Borne Encephalitis Virus in Latvia Using Standard and Subtype-Specific NS1-Based ELISA Assays

Zane Freimane iD, Gerhard Dobler iD, Guntis Karelis iD, Lidia Chitimia-Dobler, Oksana Savicka, Dace Zavadska iD

Pathogens · 2025

DOI: 10.3390/pathogens14111115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Zane Freimane und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Rīga Stradinš University, 1007 Riga, Latvia. Hauptthemen laut MEDLINE: Antibodies, Viral, Encephalitis, Tick-Borne, Viral Nonstructural Proteins, Encephalitis Viruses, Tick-Borne. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rīga Stradinš Universit, Pfizer, Rīga Stradinš University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Latvia is one of the most endemic tick-borne encephalitis (TBE) countries in Europe. However, assessing TBE seroprevalence and true infection rates has been challenging. Current diagnostics cannot reliably distinguish between immune responses induced by natural infection from those induced by vaccination, especially in TBE endemic countries with recommended immunisation programmes. A recently developed ELISA targeting antibodies against TBEV non-structural protein 1 (NS1) offers improved specificity for natural infection and can differentiate among three clinically relevant TBEV subtypes.

Methods

We conducted a cross-sectional TBEV seroprevalence study in the Latvian population during 2019–2022, consisting of two pools: 1020 residents living in different regions of Latvia and 200 random Latvian Biobank blood samples. We used the standard anti-TBEV IgG ELISA (VIDITEST, VIDIA, Czech Republic) for the screening and detection of TBEV (whole virus) IgG antibodies and the newly established research-use anti-TBEV NS1 IgG ELISA for the detection of subtype-specific TBEV NS1 IgG antibodies against three virus subtypes: European, Siberian and Far Eastern.

Results

The total TBEV seroprevalence among 1020 residents was 39.7%, representing all age cohorts of the population from all regions of Latvia. In total, 33.4% of the enrolled population were vaccinated against TBE with at least one dose of the TBE vaccine. Among the unvaccinated population, 16.3% had positive TBEV-specific IgG antibodies by standard ELISA. On the contrary, NS1-specific antibodies, indicating past natural infection, were detected in only 4.3% of the overall study population. Subtype differentiation revealed infections from all three major TBEV subtypes present in Latvia.

Conclusions

In conclusion, this population-based study highlights a high risk of TBE in Latvia, with substantial seroprevalence even among unvaccinated individuals. The NS1-based ELISA enhances the accuracy of TBE surveillance and offers important clinical utility by facilitating more reliable diagnosis and case classification, regardless of vaccination status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, ViralEncephalitis, Tick-BorneViral Nonstructural ProteinsEncephalitis Viruses, Tick-BorneHumansLatviaSeroepidemiologic StudiesEnzyme-Linked Immunosorbent AssayMaleFemaleAdultMiddle AgedCross-Sectional StudiesAgedImmunoglobulin GAdolescentYoung AdultChildChild, PreschoolAged, 80 and over

Stichwörter der Autor:innen

LatviaNS1 ELISATBEV antibodiesorthoflavivirusseroprevalence

Substanzen

Antibodies, ViralViral Nonstructural ProteinsImmunoglobulin G

Autor:innen und Institutionen

  • Department of Paediatrics, Rīga Stradinš University, 1007 Riga, Latvia.
  • Children's Clinical University Hospital, 1004 Riga, Latvia.
  • Bundeswehr Institute of Microbiology, National TBEV Consultant Laboratory, 80937 Munich, Germany.
  • Department of Tropical Medicine and Infectious Diseases, Ludwig Maximilians University, 80802 Munich, Germany.
  • Department of Parasitology, University of Hohenheim, 70599 Stuttgart, Germany.
  • Department of Neurology and Neurosurgery, Riga East University Hospital, 1079 Riga, Latvia.

ORCID-Profile: Zane Freimane, Gerhard Dobler, Guntis Karelis, Dace Zavadska

Förderung

  • Rīga Stradinš Universit
  • Pfizer
  • Rīga Stradinš University
  • commercial source, Pfizer

Zitieren

APA

Freimane, Z., Dobler, G., Karelis, G., Chitimia-Dobler, L., Savicka, O., & Zavadska, D. (2025). Seroprevalence of Tick-Borne Encephalitis Virus in Latvia Using Standard and Subtype-Specific NS1-Based ELISA Assays. Pathogens. https://doi.org/10.3390/pathogens14111115

Vancouver

Freimane Z, Dobler G, Karelis G, Chitimia-Dobler L, Savicka O, Zavadska D. Seroprevalence of Tick-Borne Encephalitis Virus in Latvia Using Standard and Subtype-Specific NS1-Based ELISA Assays. Pathogens. 2025. doi:10.3390/pathogens14111115

BibTeX
@article{Freimane2025,
  author = {Freimane, Zane and Dobler, Gerhard and Karelis, Guntis and Chitimia-Dobler, Lidia and Savicka, Oksana and Zavadska, Dace},
  title = {Seroprevalence of Tick-Borne Encephalitis Virus in Latvia Using Standard and Subtype-Specific NS1-Based ELISA Assays},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14111115}
}
Kostenlos starten →